UniDoc Health Corp.: UniDoc Exclusively Licenses Technology for Global Markets ()

IRW-PRESS: UniDoc Health Corp.: UniDoc exclusively licenses technology for global markets

UniDoc exclusively licenses technology for global markets

This press release may not be distributed through US media outlets.

Vancouver, BC – June 9, 2022 – UniDoc Health Corp. (UniDoch Health or the Company) (WKN: A3C87U – CSE: UDOC – ISIN: CA90468F1027), an innovator in the field of telemedicine, is pleased to announce that it has modified its license agreement to enable exclusive commercial activities worldwide.

On June 8, 2021, the Company, through its wholly owned subsidiary, UniCheck Holdings Corp., closed. (UniCheck) entered into a multi-year agreement with Italy’s UniCheck SRL for the development and commercialization of certain UniCheck technologies and related intellectual property. Pursuant to this license agreement, UniCheck granted the Company an exclusive license to use the intellectual property rights, brands, know-how and technologies, including the rights to manufacture, have manufactured, produce, market, sell, distribute goods and services , import, export and otherwise exploit the intellectual property rights and UniCheck Technologies in North and South America.

Effective immediately, the amended agreement officially removes all territorial restrictions of the original agreement and grants UniCheck Holding and consequently UniDoc Health Corp. the exclusive license to use and deploy the intellectual property of UniCheck SRL worldwide. In particular, the Company will use software licensed and developed by UniCheck in connection with the Virtual Care Solutions Model (such as its cloud computing software), UniCheck’s physical cabin and kiosk designs and other hardware designed and licensed by UniCheck SRL (such as medical devices) use.

The company and UniCheck SRL also agreed to collaborate in the development, improvement, marketing and sale of new products and services related to UniCheck technologies. The amendment also grants Unicheck the non-exclusive and transferrable license to improve the intellectual property rights of UniCheck SRL and to develop new intellectual property rights derived from the UniCheck technologies and related intellectual property rights. The Company has the right to sub-license the rights, privileges and licenses granted under the License Agreement anywhere in the world.

Antonio Baldassare, CEO of UniDoc, states: “We are pleased to be able to make this license change official. As demonstrated by our recent contract in the US and nationwide agreements in Ghana and Nigeria, the demand for accessible healthcare is a proven global need. UniDoc is pleased to be able to offer its technology and services to the global market and anticipates additional global interest as we are now able to capitalize on new market opportunities We believe this is a significant milestone which we hope will be achieved He will help increase shareholder value as we continue to grow the business.”

Im Namen des Board of Directors,

Kind regards,

Antonio Baldassarre

CEO, President & Director

UniDoch Health Corp. (CSE: UDOC)

As part of the Company’s disclosure requirements as a public issuer, current financial and material reports can be viewed under the Company’s profile on the System for Electronic Document Analysis and Retrieval (SEDAR) at

About UniDoc Health Corp. (CSE: UDOC)

UniDoc is developing a telehealth solution designed as an independent virtual remote clinic in a private kiosk where patients can get advice like in a doctor’s office. Telehealth opens the doors to a large segment of the population who do not have access, experience or understanding of online computer technology. The company believes that physical accessibility is key to its business proposition. UniDoc aims to increase shareholder value by delivering an excellent product and a sophisticated commercial network within a fast timeframe. The UniDoc team appreciates your commitment, your questions and your interest. So please keep in touch and invite anyone interested in our story to visit our website and subscribe to receive the latest information on our activities, events and progress. You are also invited to follow us on social media on Facebook, Twitter or Instagram.

For more information please contact:

UniDoc Investor Relations

Tel: +1 778.383.6731

Email: [email protected]

Matt Chatterton, Director

Tel: +1 778.613.2082

Email: [email protected]

Media Inquiries

[email protected]

About this press release:

The German translation of this press release is brought to you by – your news portal for precious metals and commodity stocks. For more information, see

Legal Notice

This press release contains statements and information that, if they are not historical facts, may constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking information may include financial and other projections, and statements about future plans, goals or economic performance, or the assumptions underlying them. In some cases, forward-looking statements are qualified by words such as “may”, “would”, “could”, “will”, “likely”, “except”, “anticipate”, “believe”, “intend”, “plan”, ” forecast”, “project”, “estimate”, “outlook” or the negative thereof or other similar expressions relating to matters which are not historical facts. Examples of such statements include, but are not limited to, statements regarding the Company’s principal product offering and its characteristics, entering into and terms of a definitive agreement with Partner upon satisfactory test results, the potential for placement of the Company’s products in pharmacies and other locations throughout the Republic Ghana, the expected benefits of partnering with the partner and how the company will commercialize the telemedicine platform.

Forward-looking information is based on management’s assumptions, estimates, analyzes and opinions made in light of their experience and perception of trends, current conditions and anticipated developments and other factors that management believed to be relevant and reasonable at the time the statements were made holds, but which may turn out to be wrong. Significant factors and assumptions used in developing the forward-looking information contained in this press release include, but are not limited to, the continued commitment of key personnel and qualified employees to the Company, the Company’s ability to obtain additional financing conditions, the conditions of competition in the industries in which the company operates, as well as the laws applicable to the company and changes thereto.

Forward-looking information involves known and unknown risks, uncertainties and other factors that could cause the Company’s actual results, performance or achievements to differ materially from the results, performance or achievements expressed or implied in the forward-looking information, including without limitation on, risks related to the company’s future business plans; risks that the Company will be unable to retain its key personnel; Risks that the Company will be unable to secure financing on reasonable terms or at all and all other risks described under the heading “Risk Factors” in the Company’s final prospectus dated December 2, 2021. Accordingly, readers should not place undue reliance on such forward-looking information. In addition, any forward-looking information speaks only as of the date on which it is made. New factors arise from time to time and it is not possible for management to do so to anticipate all such factors and to evaluate in advance the effect of each of these factors on the Company’s business or the extent to which any one factor or combination of factors could cause actual results to differ materially from those contained in the forward-looking information The Company undertakes no obligation to update any forward-looking information to conform to information or events after the date on which it was made or to reflect the occurrence of unanticipated events, except as required by law, ei including securities laws.

The CSE accepts no responsibility for the adequacy or accuracy of this press release.

The original English message can be found under the following link:

The translated message can be found under the following link:


The latest press releases from this company straight to your inbox:

Announcement transmitted by The sender is responsible for the content.

Reprint permitted free of charge provided the source is acknowledged.